|
n
|
7
|
7
|
1.000
|
|
Age in years
|
60.0 (56.0, 67.0)
|
60.0 (53.0, 63.0)
|
0.520
|
|
Sex
|
5F:2 M
|
5F:2 M
|
1.000
|
|
MODS
|
4.0 (1.0, 7.0)
|
5.0 (3.0, 7.0)
|
0.400
|
|
SOFA
|
4.0 (3.0, 9.0)
|
5.0 (4.0, 11.0)
|
0.334
|
|
Comorbidities, n (%)
| | | |
|
Hypertension
|
4 (57.1)
|
6 (85.7)
|
0.559
|
|
Diabetes
|
2 (28.6)
|
3 (42.9)
|
1.000
|
|
Chronic kidney disease
|
1 (14.3)
|
0 (0)
|
1.000
|
|
Cancer
|
1 (14.3)
|
1 (14.3)
|
1.000
|
|
Admission laboratory values
| | | |
|
WBC (× 109/L)
|
8.2 (3.8, 12.9)
|
19.3 (13.6, 24.8)
|
0.018*
|
|
Neutrophils (× 109/L)
|
7.3 (3.8, 11.1)
|
13.0 (11.7, 22.2)
|
0.025*
|
|
Lymphocytes (× 109/L)
|
0.7 (0.6, 1.0)
|
1.4 (0.4, 1.7)
|
0.608
|
|
Platelets (× 109/L)
|
202 (119, 225)
|
212 (145, 291)
|
0.565
|
|
Haemoglobin (g/L)
|
122 (104, 137)
|
123 (98, 137)
|
0.898
|
|
Creatinine (µmol/L)
|
68 (45, 184)
|
65 (49, 80)
|
0.609
|
|
p:F ratio
|
124 (69, 202)
|
172 (132, 304)
|
0.317
|
|
Admission chest X-ray findings, n (%)
| | | |
|
Bilateral pneumonia
|
7 (100)
|
1 (14.3)
|
0.005*
|
|
Unilateral pneumonia
|
0 (0)
|
4 (57.1)
|
0.070
|
|
Interstitial infiltrates
|
0 (0)
|
1 (14.3)
|
1.000
|
|
Normal
|
0 (0)
|
1 (14.3)
|
1.000
|
|
Sepsis diagnosis
| | | |
|
Suspected
|
0 (0)
|
4 (57.1)
|
0.070
|
|
Confirmed
|
7 (100)
|
3 (42.9)
|
0.070
|
|
Interventions during study
| | | |
|
Antibiotics
|
7 (100)
|
7 (100)
|
1.000
|
|
Anti-virals
|
3 (42.9)
|
0 (0)
|
0.192
|
|
Steroids
|
1 (14.3)
|
2 (28.6)
|
1.000
|
|
Vasoactive medications
|
5 (71.4)
|
5 (71.4)
|
1.000
|
|
Renal replacement therapy
|
1 (14.3)
|
0 (0)
|
1.000
|
|
High-flow nasal cannula
|
3 (42.9)
|
1 (14.3)
|
0.559
|
|
Non-invasive mechanical ventilation
|
4 (57.1)
|
7 (100)
|
0.192
|
|
Invasive mechanical ventilation
|
5 (71.4)
|
6 (85.7)
|
1.000
|
|
ICU outcome
| | | |
|
Survived
|
5 (71.4)
|
7 (100)
|
0.462
|
